PeproMene Bio
Irvine, US · Founded 2016 · California corporation · 1 known investors
Founders & leadership
HL
Hyukjong LeeNamed on SEC filing
ST
Sun Tae HwangNamed on SEC filing
YR
Young Rae ChoiNamed on SEC filing
HW
Hong Woo KimNamed on SEC filing
YK
Yung Ki ParkNamed on SEC filing
Investors · 1
Also in the syndicate · 1
Institute for Follicular Lymphoma Innovationlead
Reported raises · per SEC filings
Form D private placements$40.2M disclosed across 1 of 2 rounds · 2017–2024
▶$40.2MraisedJun 2018 · 17 investors · BiotechnologyRule 506(b)
▶$40.2MraisedJun 2018 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hyukjong LeeDirector
- Sun Tae HwangDirector
- Young Rae ChoiDirector
- Hong Woo KimExecutive Officer, Director
- Yung Ki ParkExecutive Officer, Director
- Offering amount
- $40.2M
- Amount sold
- $40.2M
- Minimum investment
- $1K
- First sale
- Jul 2017
- Incorporated
- Corporation, California, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has PeproMene Bio raised?
- PeproMene Bio has disclosed $40.2M raised across 1 of its 2 known rounds.
- Where is PeproMene Bio headquartered?
- PeproMene Bio is headquartered in Irvine, US.